Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.

Zhang M, Gao L, Liu X, Dong F, Su Q, Zhang Y, Li F, Wang H, Han P

DOI: 10.1155/2022/3181133
Published: 2022
Container: Evidence-based complementary and alternative medicine : eCAM
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2022/3181133,
  title = {Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.},
  author = {Zhang M and Gao L and Liu X and Dong F and Su Q and Zhang Y and Li F and Wang H and Han P},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/3181133},
  url = {https://doi.org/10.1155/2022/3181133}
}

RIS

TY  - JOUR
TI  - Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.
AU  - Zhang M
AU  - Gao L
AU  - Liu X
AU  - Dong F
AU  - Su Q
AU  - Zhang Y
AU  - Li F
AU  - Wang H
AU  - Han P
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/3181133
UR  - https://doi.org/10.1155/2022/3181133
ER  -

APA

M, Z., L, G., X, L., F, D., Q, S., Y, Z., F, L., H, W., & P, H. (2022). Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/3181133

Source records

pubmed · retrieved 2026-09-25T05:00:47.653Z
europe-pmc · retrieved 2026-09-25T05:00:47.684Z